Anna L. Means

4.7k total citations · 2 hit papers
48 papers, 3.7k citations indexed

About

Anna L. Means is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Anna L. Means has authored 48 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 24 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Anna L. Means's work include Pancreatic function and diabetes (20 papers), Pancreatic and Hepatic Oncology Research (17 papers) and TGF-β signaling in diseases (7 papers). Anna L. Means is often cited by papers focused on Pancreatic function and diabetes (20 papers), Pancreatic and Hepatic Oncology Research (17 papers) and TGF-β signaling in diseases (7 papers). Anna L. Means collaborates with scholars based in United States, Japan and Australia. Anna L. Means's co-authors include Lorraine J. Gudas, Peggy Farnham, Robert J. Coffey, Taka‐aki Matsuoka, M. Kay Washington, Isabella Artner, Kevin C. Ray, Steven D. Leach, Christopher V.E. Wright and Eva Henderson and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anna L. Means

47 papers receiving 3.6k citations

Hit Papers

The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal St... 2012 2026 2016 2021 2012 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna L. Means United States 28 1.9k 1.4k 1.4k 956 376 48 3.7k
Noreen Luetteke United States 22 1.9k 1.0× 1.5k 1.0× 593 0.4× 571 0.6× 961 2.6× 34 4.0k
Nanda R. Rodrigues United Kingdom 20 2.3k 1.2× 765 0.5× 754 0.5× 1.1k 1.2× 534 1.4× 34 3.8k
Christophe E. Pierreux Belgium 32 1.9k 1.0× 440 0.3× 1.2k 0.9× 676 0.7× 177 0.5× 83 3.5k
M.G. Byers United States 30 2.1k 1.1× 453 0.3× 624 0.5× 732 0.8× 448 1.2× 54 3.6k
Esther Danenberg Netherlands 9 3.4k 1.8× 2.0k 1.4× 642 0.5× 732 0.8× 349 0.9× 9 5.1k
Muhsen Al-Dhalimy United States 23 2.7k 1.4× 512 0.4× 3.0k 2.2× 778 0.8× 221 0.6× 28 6.2k
P. Sivaramakrishna Rachakonda Germany 25 1.9k 1.0× 931 0.7× 305 0.2× 305 0.3× 291 0.8× 45 3.4k
William C. Bowen United States 33 2.1k 1.1× 516 0.4× 2.5k 1.8× 241 0.3× 273 0.7× 66 5.2k
Wim de Lau Netherlands 15 3.2k 1.7× 1.6k 1.1× 444 0.3× 837 0.9× 334 0.9× 20 4.5k
Pellegrino Rossi Italy 36 2.6k 1.4× 329 0.2× 452 0.3× 1.5k 1.5× 345 0.9× 81 4.7k

Countries citing papers authored by Anna L. Means

Since Specialization
Citations

This map shows the geographic impact of Anna L. Means's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Means with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Means more than expected).

Fields of papers citing papers by Anna L. Means

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Means. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Means. The network helps show where Anna L. Means may publish in the future.

Co-authorship network of co-authors of Anna L. Means

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Means. A scholar is included among the top collaborators of Anna L. Means based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Means. Anna L. Means is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jing, James S. Lewis, Thomas Andl, et al.. (2024). Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma. The Journal of Pathology. 264(1). 4–16. 3 indexed citations
2.
McDonald, Oliver G., Anna L. Means, Richard M. Peek, et al.. (2021). Exposure to p40 in Early Life Prevents Intestinal Inflammation in Adulthood Through Inducing a Long-Lasting Epigenetic Imprint on TGFβ. Cellular and Molecular Gastroenterology and Hepatology. 11(5). 1327–1345. 13 indexed citations
3.
Shi, Chanjuan, Fong Cheng Pan, M. Kay Washington, et al.. (2019). Differential Cell Susceptibilities to Kras in the Setting of Obstructive Chronic Pancreatitis. Cellular and Molecular Gastroenterology and Hepatology. 8(4). 579–594. 14 indexed citations
4.
Choi, Eunyoung, Anna L. Means, Robert J. Coffey, & James R. Goldenring. (2018). Active Kras Expression in Gastric Isthmal Progenitor Cells Induces Foveolar Hyperplasia but Not Metaplasia. Cellular and Molecular Gastroenterology and Hepatology. 7(1). 251–253.e1. 13 indexed citations
5.
Erdoğan, Begüm, Mingfang Ao, Lauren M. White, et al.. (2017). Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin. The Journal of Cell Biology. 216(11). 3799–3816. 421 indexed citations breakdown →
6.
Gaskill, Christa, Erica J. Carrier, Jonathan A. Kropski, et al.. (2017). Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. Journal of Clinical Investigation. 127(6). 2262–2276. 34 indexed citations
7.
Shi, Chanjuan, M. Kay Washington, Rupesh Chaturvedi, et al.. (2014). Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage–stellate cell interaction. Laboratory Investigation. 94(4). 409–421. 62 indexed citations
8.
Pekala, Kelly R., Peter Kropp, Christine Petersen, et al.. (2014). Loss of HNF6 expression correlates with human pancreatic cancer progression. Laboratory Investigation. 94(5). 517–527. 19 indexed citations
9.
Moss, M. Elizabeth, Jeffrey L. Franklin, James N. Higginbotham, et al.. (2013). Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia. Oncogene. 33(7). 823–831. 39 indexed citations
10.
Powell, Anne E., Yang Wang, Yina Li, et al.. (2012). The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor. Cell. 149(1). 146–158. 528 indexed citations breakdown →
11.
Westmoreland, Joby J., Yiannis Drosos, Jianming Ye, et al.. (2012). Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation. Developmental Dynamics. 241(3). 583–594. 20 indexed citations
12.
Vanderpool, Charles, Erin E. Sparks, Kari A. Huppert, et al.. (2011). Genetic Interactions Between Hepatocyte Nuclear Factor–6 and Notch Signaling Regulate Mouse Intrahepatic Bile Duct Development in Vivo. Hepatology. 55(1). 233–243. 32 indexed citations
13.
Means, Anna L., Yanwen Xu, Aizhen Zhao, Kevin C. Ray, & Guoqiang Gu. (2008). A CK19CreERT knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. genesis. 46(6). 318–323. 153 indexed citations
14.
Means, Anna L., Ingrid M. Meszoely, Kazufumi Suzuki, et al.. (2005). Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development. 132(16). 3767–3776. 262 indexed citations
15.
Nomura, Sachiyo, Stephen H. Settle, Charles M. Leys, et al.. (2005). Evidence for Repatterning of the Gastric Fundic Epithelium Associated With Ménétrier’s Disease and TGFα Overexpression. Gastroenterology. 128(5). 1292–1305. 61 indexed citations
16.
Means, Anna L., Anna Chytil, Harold L. Moses, et al.. (2005). Keratin 19 gene drives Cre recombinase expression throughout the early postimplantation mouse embryo. genesis. 42(1). 23–27. 11 indexed citations
17.
Samaras, Susan, Li Zhao, Anna L. Means, et al.. (2003). The Islet Cell-enriched RIPE3b1/Maf Transcription Factor Regulates pdx-1 Expression. Journal of Biological Chemistry. 278(14). 12263–12270. 53 indexed citations
18.
Means, Anna L. & Steven D. Leach. (2001). Lineage commitment and cellular differentiation in exocrine pancreas. Pancreatology. 1(6). 587–596. 11 indexed citations
19.
Means, Anna L. & Lorraine J. Gudas. (1995). THE ROLES OF RETINOIDS IN VERTEBRATE DEVELOPMENT. Annual Review of Biochemistry. 64(1). 201–233. 243 indexed citations
20.
Means, Anna L. & Peggy Farnham. (1990). Transcription Initiation from the Dihydrofolate Reductase Promoter Is Positioned by HIP1 Binding at the Initiation Site. Molecular and Cellular Biology. 10(2). 653–661. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026